Sponsor or institution
Clinical trials and research at Alkeus Pharmaceuticals, Inc.
As of November 12, 2026, Find a Trial lists 1 clinical trial run by Alkeus Pharmaceuticals, Inc. that is recruiting, in United States. By phase: Phase 3 (1). There are also 1 NIH-funded research project at this institution, with $500,000 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 1Clinical trials
- 1NIH research projects
- 1Country
All recruiting trials (1)
-
ALK-001 to slow progression of Stargardt disease
This trial will test whether ALK-001 can slow vision loss in people aged 8 to 45 with ABCA4-related Stargardt disease.
NIH-funded research (1)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Investigating a new oral treatment for Stargardt disease to slow vision loss.
This study is testing a new pill called ALK-001 that aims to help people with Stargardt disease by slowing down vision loss caused by a problem with a specific gene.
Quick answers
How many clinical trials run by Alkeus Pharmaceuticals, Inc. are recruiting right now?
1, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.